Vimarsana
Biggest News Aggregation in the World

Page 31 - Molecular Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molecular Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molecular Testing Today - Breaking & Trending Today

Global IVD Procedure Volumes (2020-2025) Report 2021: Gold Standard for Sizing the Market Opportunity for New Entrants with Diagnostic Products - Vimarsana News

Global IVD Procedure Volumes (2020-2025) Report 2021: Gold Standard for Sizing the Market Opportunity for New Entrants with Diagnostic Products

ResearchAndMarkets.com's offering. In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in the IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner. The report includes estimates of average fee...

Neuberg Diagnostics launches clinical laboratory in the US - The Hindu BusinessLine - Vimarsana News

Neuberg Diagnostics launches clinical laboratory in the US - The Hindu BusinessLine

Neuberg Diagnostics launches clinical laboratory in the US May 03, 2021 × Introduces Covid-19 molecular testing to detect active SARS CoV-2 virus infections that is of immediate public health priority in North America Chennai-based Neuberg Diagnostics on Monday announced the start of its clinical laboratory operations in North Carolina in the US. The North Carolina laboratory, known as NCGM Inc (Neuberg Centre for Genomic Medicine), will focus on genomic and molecular testing based on new generation sequencing techniques. In a press release, the Diagnostics group said, NCGM has introduced...

Global IVD Procedure Volumes Report 2020-2025: The Gold Standard for Sizing the Market Opportunity for New Entrants with Diagnostic Products - Vimarsana News

Global IVD Procedure Volumes Report 2020-2025: The Gold Standard for Sizing the Market Opportunity for New Entrants with Diagnostic Products

Share this article Share this article ResearchAndMarkets.com's offering. The global volume of IVD procedures is forecast to increase 7.9% annually to 111.3 billion in 2025.  In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers.  The same timeframe will see worldwide sales of IVD products expanding 5.4% per year to $95 billion. Blood glucose monitoring activities will account for approximately 76% of testing volume and about $20 billion of product sales. ...

Antimicrobial Susceptibility Test Market - Detailed Analysis of Current and Future Industry Figures - Vimarsana News

Antimicrobial Susceptibility Test Market - Detailed Analysis of Current and Future Industry Figures

Antimicrobial Susceptibility Test Market - Detailed Analysis of Current and Future Industry Figures The Global Antimicrobial Susceptibility Test Market 2021-2027 Report provides an in-depth analysis on the studied market that helps to seem at the longer term requirement also as prediction. BriefingWire.com, 3/13/2021 - The Global Antimicrobial Susceptibility Test Market 2021-2027 Report provides an in-depth analysis on the studied market that helps to seem at the longer term requirement also as prediction. The antimicrobial susceptibility test ...

China In Vitro Diagnostics (IVD) Market Growth Analysis By Revenue, Size, Share, Technology, Applications, Trends, Demand Forecast to 2025 - Vimarsana News

China In Vitro Diagnostics (IVD) Market Growth Analysis By Revenue, Size, Share, Technology, Applications, Trends, Demand Forecast to 2025

Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following